AMENDED & RESTATED ASSET CONTRIBUTION AGREEMENTAsset Contribution Agreement • February 12th, 2018 • BioXcel Therapeutics, Inc. • Pharmaceutical preparations • Connecticut
Contract Type FiledFebruary 12th, 2018 Company Industry JurisdictionThis Amended & Restated Asset Contribution Agreement (this “Agreement”) is entered into as of November 7, 2017 (the “Execution Date”), by and between BioXcel Corporation, a Delaware corporation located at 780 East Main Street, Branford, CT 06405 (“BioXcel”), and BioXcel Therapeutics, Inc., a Delaware corporation located at 780 East Main Street, Branford, CT 06405 (“BTI”).
AMENDED & RESTATED ASSET CONTRIBUTION AGREEMENTAsset Contribution Agreement • November 13th, 2017 • BioXcel Therapeutics, Inc. • Pharmaceutical preparations • Connecticut
Contract Type FiledNovember 13th, 2017 Company Industry JurisdictionThis Amended & Restated Asset Contribution Agreement (this “Agreement”) is entered into as of November 7, 2017 (the “Execution Date”), by and between BioXcel Corporation, a Delaware corporation located at 780 East Main Street, Branford, CT 06405 (“BioXcel”), and BioXcel Therapeutics, Inc., a Delaware corporation located at 780 East Main Street, Branford, CT 06405 (“BTI”).